Mangoceuticals (MGRX) Interest Coverage Ratio (2025)

Mangoceuticals' (MGRX) quarterly Interest Coverage Ratio came in at 677.9 in Q4 2025, up 781.68% quarter-over-quarter from 99.45 in Q3 2025.

Mangoceuticals (MGRX) Interest Coverage Ratio (2025) Analysis & Trends

Mangoceuticals has disclosed Interest Coverage Ratio across 1 years of filings, most recently posting 677.9 for Q4 2025.

Interest Coverage Ratio for Q4 2025 came in at 677.9, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 22.25 (down 107.55% YoY), and the FY2025 annual result was 41.88, up 68.62% from the prior year.
Interest Coverage Ratio came in at 677.9 for Q4 2025 at Mangoceuticals, up from 99.45 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 677.9 in Q4 2025 to a low of 242.79 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	3.15
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	8.18
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	3.90
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	Mangoceuticals	5.25 Mn	5.06 Mn	29,001.00	-

Download Data